Status:
WITHDRAWN
Influence of Fatigue on the Walking Pattern in Cerebral Palsy Patients.
Lead Sponsor:
Fondation Lenval
Conditions:
Cerebral Palsy
Eligibility:
All Genders
7-18 years
Brief Summary
To date, studies do not study the influence of external disturbing factors on the market. The main hypothesis is that the stopping of walking in paralyzed cerebral patients is mainly due to an increa...
Detailed Description
In most studies, the study of the gait of cerebral palsy patients is done through quantified walking analysis tests, objectively evaluating the kinetic and kinematic parameters, associated with the me...
Eligibility Criteria
Inclusion
- children aged 7 to 18 years (diplegic, hemiparetic or tetraparetic) requiring treatment with botulinum toxin
- followed at the Lenval Foundation
- walking alone more than 6 minutes
- parental information and no disagreement
Exclusion
- Modification of spasticity treatments within 6 months of evaluation: baclofen pump, oral baclofen, retraction surgery (tenotomy, tendon lengthening, arthrodesis ...)
- dyskinesia
- Cognitive disorders in children that do not allow the use of GRAIL
- Contraindication to Botulinum Toxin (myasthenia, hypersensitivity and infections)
- Contraindication to physical activity (intercurrent pathology)
Key Trial Info
Start Date :
November 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04129749
Start Date
November 17 2019
End Date
December 1 2021
Last Update
July 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Pédiatriques de Nice CHU-Lenval
Nice, France